1. Home
  2. RLMD vs RETO Comparison

RLMD vs RETO Comparison

Compare RLMD & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • RETO
  • Stock Information
  • Founded
  • RLMD 2004
  • RETO 1999
  • Country
  • RLMD United States
  • RETO China
  • Employees
  • RLMD N/A
  • RETO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • RETO Multi-Sector Companies
  • Sector
  • RLMD Health Care
  • RETO Consumer Discretionary
  • Exchange
  • RLMD Nasdaq
  • RETO Nasdaq
  • Market Cap
  • RLMD 22.0M
  • RETO 24.7M
  • IPO Year
  • RLMD N/A
  • RETO 2017
  • Fundamental
  • Price
  • RLMD $0.83
  • RETO $3.19
  • Analyst Decision
  • RLMD Hold
  • RETO
  • Analyst Count
  • RLMD 4
  • RETO 0
  • Target Price
  • RLMD $4.25
  • RETO N/A
  • AVG Volume (30 Days)
  • RLMD 840.1K
  • RETO 36.0K
  • Earning Date
  • RLMD 05-12-2025
  • RETO 06-26-2025
  • Dividend Yield
  • RLMD N/A
  • RETO N/A
  • EPS Growth
  • RLMD N/A
  • RETO N/A
  • EPS
  • RLMD N/A
  • RETO N/A
  • Revenue
  • RLMD N/A
  • RETO $1,828,976.00
  • Revenue This Year
  • RLMD N/A
  • RETO N/A
  • Revenue Next Year
  • RLMD N/A
  • RETO N/A
  • P/E Ratio
  • RLMD N/A
  • RETO N/A
  • Revenue Growth
  • RLMD N/A
  • RETO N/A
  • 52 Week Low
  • RLMD $0.24
  • RETO $2.86
  • 52 Week High
  • RLMD $4.47
  • RETO $18.20
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 72.41
  • RETO 42.18
  • Support Level
  • RLMD $0.65
  • RETO $2.90
  • Resistance Level
  • RLMD $0.77
  • RETO $3.73
  • Average True Range (ATR)
  • RLMD 0.10
  • RETO 0.24
  • MACD
  • RLMD 0.02
  • RETO -0.05
  • Stochastic Oscillator
  • RLMD 86.00
  • RETO 28.71

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: